pe
pep-05152 v1 CC-BY-SA-4.0

ERBB2 blood-sugar-regulating peptide

An experimental peptide that switches on the same body target as diabetes and weight-loss drugs like Ozempic, helping control blood sugar; not an approved medicine.

statuscomputed targetGLP-1R length31 aa refs2
metabolic
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.743
pTM0.766
avg pLDDT70.8
ranking score0.715
STRUCTURE · PEP-05152 × GLP-1R
ranking0.715
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence31 aa
15101520253031
LHCPALVTYNTDTFES MPNPEGRYTFGASCV
in the news 136 articles
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.7428394556045532 boltz-2
ranking score 0.7149079442024231 boltz-2
structural qualityopenfold3
metricvaluenote
gpde1.101global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Leu-His-Cys-Pro-Ala-Leu-Val-Thr-Tyr-Asn-Thr-Asp-Thr-Phe-Glu-Ser-Met-Pro-Asn-Pro-Glu-Gly-Arg-Tyr-Thr-Phe-Gly-Ala-Ser-Cys-Val
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). ERBB2 blood-sugar-regulating peptide (pep-05152, v1). PeptideModel. https://peptidemodel.com/card/pep-05152
@peptide{pep05152,
  sequence = {LHCPALVTYNTDTFESMPNPEGRYTFGASCV},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 2 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use